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Abstract  
Coronavirus is a beta virus that has caused a worldwide pandemic since December 2019. Many 
treatments such as antiviral drugs, immunosuppressive drugs, neutralizing antibodies, and monoclonal 
antibodies have been tested on coronavirus disease 2019 (COVID-19) that most of them were effective. 
Given that nanotechnology-based approaches have been successful in detection and treatment of viral 
systems such as human immunodeficiency virus (HIV), influenza A virus subtype H1N1 and Middle 
East respiratory syndrome coronavirus (MERS-CoV), they also seem to be effective in detecting and 
treating COVID-19. Nanotechnology is used in various methods for early and rapid diagnosis of the 
disease. Nanoparticles can be used in products for the diagnosis, treatment and prevention of COVID-
19. These substances are very effective in the controlled delivery of antiviral drugs and biomolecules 
and they are also used in the manufacture of personal safety equipment, widely, and the production of 
anti-virus coatings for surfaces, air filters and the production of vaccines. In general, nanomaterial can 
play an important role in controlling the disease, based on strategies to prevent the virus from entering 
the host cell, inhibiting virus replication, virus delivery systems, and nano-based vaccines. 
Nanotechnology is a multidisciplinary tool that can offer a variety of solutions based on disease 
prevention, diagnosis and treatment strategies. 
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1. Introduction 
The corona pandemic that has occurred in the 
world since the last days of 2019 is related to a virus 
called coronavirus-2019 (COVID-19) and belongs to 
the beta virus family along with Severe acute 
respiratory syndrome coronavirus-2 (SARS-CoV-2) 
and Middle East respiratory syndrome coronavirus 
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(MERS-CoV) [1]. This virus has a single-stranded 
positive RNA genome [2]. The virus attaches to the 
human angiotensin converting enzyme-2 (ACE-2) and 
binds to the host cell. This enzyme is a receptor for the 
SARS-CoV-2 virus in the host cell [3]. They cause 
several diseases in humans and animals, including 
 © The Author(s) 2021 
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respiratory, intestinal, hepatic, and nervous systems 
[4]. 
The rate of human-to-human transmission of 
coronavirus is significantly high and causes a wide 
range of clinical manifestations in patients infected 
with the virus [5]. However, the reproductive number 
and transmission way are not yet completely 
understood, the routes of transmission with and 
without symptoms and the role of environmental 
factors should be better known. Widespread 
geographical epidemics and prevalence in large 
populations of the world, rapid transmission, 
recurrent infections and genomic alteration [6, 7], 
create difficult barriers to the development of ways to 
prevent, control, and treat this disease [8, 9]. 
A wide range of possible treatments is being 
tested. Based on the SARS-CoV-2 life cycle and its 
structure, the treatments proposed for Covid-19 have 
been antiviral drugs, immunosuppressive drugs, 
neutralizing and monoclonal antibodies [10], and 
vaccines. 
Antiviral drugs effect by inhibiting ribonucleic acid 
(RNA) polymerase, viral protease, membrane 
occlusion, and widespread of antiviral effects [10]. 
Currently, oxygen therapy and the use of the 
respiratory tract play a major role in the treatment of 
COVID-19 [11]. 
Recent clinical results for antiviral drugs have not 
been very satisfactory [12]. Some drugs have also been 
suggested to reduce the damage caused by SARS-CoV-
2 to the lungs [8]. In some cases, plasma therapy is also 
suggested [13]. This method of treatment is used in 
patients who are not able to produce enough 
antibodies and is a safe and effective method and 
seems to reduce mortality [14]. 
Scientists believe nanotechnology-based 
approaches could help against covid-19. Based on 
previous studies, nanotechnology can be effective in 
identifying viral systems and overcome the limitations 
of conventional methods of viral disease strategies [15, 
16]. 
In this study, in addition to reviewing the effects of 
nanotechnology in the fight against other viral 
diseases, the proposed nanotechnology-based 
solutions in the diagnosis, treatment, and prevention 
of environmental pollution caused by covid-19 are 
examined. 
 
2. Application of nanotechnology in the 
detection and treatment of viral infections 
According to previous research, nanotechnology 
has been considered in the process of diagnosis and 
treatment of many viral diseases. The use of 
luminescence electrochemical biosensors for the 
selective detection of avian influenza virus (H9N2-
AIV) [17] and the use of magnetic nanoparticles (NPs) 
for the detection of influenza A virus subtype H1N1 
virus [18] are examples of nanoparticles applications 
in virus detection. The use of poly vinyl pyrrolidone 
(PVP) coated AgNPs (30-50 nm) on HIV strains has 
also been shown to have antiviral activity [19].  
Curcumin nanoparticles also have high antiviral 
properties against the respiratory syncytial virus 
(RSV) [20]. Dendrimers have also been extensively 
studied for human immunodeficiency virus (HIV) 
disinfection applications. These nanoparticles 
suppress virus replication [21]. Lipid-based 
nanoparticles have previously been tested for the 
treatment of HIV, herpes, hepatitis B (HBV), and 
hepatitis C (HCV) viruses. These nanoparticles can 
encapsulate different classes of antiviral drugs and are 
a mediator of drug delivery to the target tissue or cell, 
as well as modulating specific biological responses 
[22]. 
Aluminum nanoparticles are another class of 
metal structures that can be used in vaccines for 
respiratory viruses such as MERS-CoV and SARS-
CoV-2. These compounds elicit cellular and humoral 
immunity responses [23]. Unsaturated liposomes also 
have an inhibitory effect against HBV, HCV, and HIV 
[22]. 
 
3. SARS-CoV-2 and nanotechnology 
insights 
Nanotechnology-based treatment strategies are a 
promising way to overcome the current limitations in 
the prevention, diagnosis, and treatment of Covid-19 
[24]. Nanomaterials can be used for disease diagnosis 
to develop simpler, cheaper, and faster methods. In 
therapy, nanosystems can be used in the controlled 
delivery of antiviral drugs and biomolecules to the 
lungs and target tissues that are used to prevent virus 
replication or inactivation of viral particles [25]. There 
are successful prospects in building safe personal 
protective equipment [25] and producing vaccines or 
immune modulators using nanotechnology [16]. 
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4. Detection of SARS-CoV-2 with 
nanotechnology 
Currently, the only way to diagnose Covid-19 
infection is to test for nucleic acid by reverse 
transcription polymerase chain reaction (RT-PCR). 
But this method also has limitations; it is not able to 
diagnose asymptomatic patients, not all health care 
centers, especially in non-urban environments, are 
equipped with sufficient PCR infrastructure. While 
accurate and early diagnosis of the disease is a vital 
requirement for essential care. Nanotechnology can 
meet these demands through nucleic acid testing 
methods, point-of-care testing (POCT), 
electrochemical sensors, and biosensors [15]. 
In the nucleic acid test method, the nucleic acid is 
amplified in nucleic acid isothermal conditions. This 
method is very sensitive, rapid, and specific [26]. 
Nanomaterials exhibit electrical and optical properties 
that have been extensively applied in the development 
of diagnostic methods such as point-of-care testing 
(POCT) biosensors. 
These substances can improve the sensitivity of 
diagnosis, rapid isolation of patients, and facilitate the 
treatment process [24]. Different types of 
nanomaterials include; nanoparticles, nanoclusters, 
quantum dots, carbon nanotubes, nanocomposites, 
etc that have been used to increase the performance of 
biosensors. Recently, deoxyribonucleic acid (DNA) 
sensor nanomaterials have been developed for simple, 
rapid, selective, low-cost, and sensitive detection of 
infectious diseases [27]. Biosensors are color-coded 
test points that can detect contaminated specimens 
through simple color changes that are visible to the 
naked eye [15]. 
A sample of these POCTs has been generated 
using gold nanoparticles to detect the MERS-CoV 
virus [28]. In another method, reverse transcription 
Loop-Mediated Isothermal Amplification (RT-LAMP) 
with nano-based biosensors has been used to detect 
COVID-19 [29].  
Electrochemical sensors are effective in detecting 
viruses due to their high sensitivity and the possibility 
of shrinkage. Gold nanoparticles (AuNPs) are one of 
the most attractive nanomaterials because they have 
electronic optical properties that can be detected by a 
variety of biosensors, especially those based on 
colorimetric, electrochemical [30]. The use of AuNPs 
in these sensors is much more effective in detecting 
viruses by immobilizing biomolecules while 
maintaining their function [31].  
 
5. Treatment of SARS-CoV-2 with 
nanotechnology 
The specific antiviral drug for SARS-CoV-2 is not 
currently available to the public [32]. Production of 
these drugs is a time-consuming process that must be 
monitored and tested for safety before use [33]. On the 
other hand, increasing virus resistance is another 
limitation of the production and use of antiviral drugs 
[15]. In some studies, nanotechnology has been widely 
applied in the treatment of this disease. 
Nanotechnology through methods such as; preventing 
viruses from entering host cells, inhibiting virus 
replication, virus transmission systems, and nano-
based vaccines is probably successful in treating the 
disease [15]. 
Also, many of the proposed treatments for covid-
19 infection that are spreading, use nano-based 
methods such as; SARS-CoV-2 virus-like particles by 
using iBio's Fast Pharming technology[15]. 
Nanoparticles (NP) (organic and inorganic) have 
been considered for some of their properties. 
Inorganic NPs (INPs) have properties such as 
luminescence, adjustable size, shape, composition, 
high surface-to-volume ratio, and the ability to expose 
multiple reciprocal locations on the surface. The most 
common types of INPs are mesoporous silica NPs, 
iron oxide NPs and metal NPs (gold, silver). Organic 
NPs include; Carbon nanotubes and graphene 
nanoparticles are polymeric and lipid NPs, 
dendrimers, extracellular vesicles (or exosomes), 
liposomes, and nanomolecules. Organic nanoparticles 
are being noticed because of their potential site-
specific targeting, drug release control, 
biodegradation, biocompatibility, and non-toxicity 
[34]. 
 
6. Pharmacological treatment 
The first step in starting a viral infection is the 
virus's attachment to the host. Nanoparticles have the 
ability to prevent the virus from adherent to the host 
cell and entering the cell [35]. One way to use 
nanoparticles to prevent the virus from entering the 
host cell is to use carbon quantum dots that if 
combined with boronic acid show stronger antiviral 
activity [36]. The use of gold nano rods in antiviral 
therapy for MERS has also been successful [37]. 
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Second, if the virus enters the host cell, the spread of 
infection can be prevented with nanoparticles, mainly 
as carriers for the delivery of antiviral molecules. 
Higher specificity, improvement of drug solubility, 
the combination of different drug molecules in one 
particle, and reduction of toxicity for the host are the 
advantages of nanoparticles in this field [15]. Some 
nanoparticles, such as Ag2S nanoclusters, can prevent 
the virus from replicating in the host body. These 
nanoparticles also play a role in enhancing the 
expression of pro-inflammatory cytokines, which are 
effective against viral infections [38]. Zinc oxide (ZnO) 
nanoparticles have similar activity and effective 
against H1N1 influenza virus infection [39] and it also 
seems to be involved in inhibiting the proliferation of 
SARS-CoV-2 [40].  
Traditional methods of prescribing antiviral drugs 
have limitations such as poor bioavailability, systemic 
toxicity, susceptibility to in vivo destruction, and short 
half-life. 
In contrast, nanotechnology drugs have 
advantages such as higher bioavailability, lower 
toxicity, protection against degradation, improved 
circulating half-life, reduced effective dose of the drug, 
the ability to cross biological barriers [41], and tissue 
or cellular targeting [42]. 
Also, nanocarriers provide the ability to control 
drug release in the target tissue, improve 
biocompatibility and reduce drug toxicity in healthy 
tissues by confining drugs [24]. Nano compounds 
such as micelles, microspheres, liposomes, and 
dendrimers have been used for better and targeted 
delivery of antiviral drugs such as efavirenz, 
zidovudine, and acyclovir [42]. 
 
7. Prevention of SARS-CoV-2 with 
nanotechnology 
7.1 Improving personal protective equipment 
(PPE) using nanotechnology 
In cases where a definitive cure for COVID-19 has 
not yet been discovered, prevention is especially 
important in vulnerable people such as the elderly, 
those with immunodeficiency, and at-risk individuals 
include healthcare professionals [43]. Although 
observing physical distance is known as the first step 
but, it is difficult to implement in the healthcare staff. 
Therefore, equipping these people with highly efficient 
safety and PPE is a very necessary step [15]. 
 
7.2 Environmental, surface disinfectants, and 
healthcare 
Studies have shown that the SARS-CoV-2 virus 
remains on the surface for a long time [44, 45], so even 
the PPE kits used may be infected with the virus [46]. 
Therefore, the production of anti-virus coatings on 
surfaces and air filtration devices can help reduce 
infection. 
Nanomaterials have the ability to prevent viral 
contamination by air and contact with contaminated 
surfaces and have the ability to sterilize protective 
equipment, especially in hospital settings [24]. 
Creating self-disinfecting surfaces is another strategy 
to prevent the spread of COVID-19. 
Coating surfaces using nanomaterials such as 
silver, zinc oxide, and copper NPs is one of these 
solutions. These compounds oxidize and release ions 
with antimicrobial properties [25, 47]. According to 
studies, controlled and long-term diffusion of ions in 
some metals, such as copper, modulates the antiviral 
properties of surfaces [48]. 
These nanoparticles are loaded into a polymer 
matrix and provide an effective antiviral coating on 
surfaces [15]. This method can also be applied to 
polypropylene masks. This method has already been 
used in the preparation of protective masks against 
influenza viruses. This was done by depositing a 
coating of silver or silica nanocoating composite on 
face masks [49]. Graphene in face masks can also 
sterilize these and allow them to be reused [50]. This 
coating is also suitable for use on surfaces in public 
places [51]. 
There are several products made of 
nanocomposites that have antimicrobial activity and 
are used in the disinfection of surfaces. CAC-717 is a 
new disinfectant consisting of calcium hydrogen 
carbonate mesoscopic crystals that are a compound 
containing mesostructured NPs and are involved in 
inactivating enveloping [52] and non-enveloping [53] 
viruses. 
Tungsten carbide nanoparticles also have 
extensive antiviral activity [54]. AgNPs also have 
various medical, environmental, and industrial 
applications as disinfectants [55]. These compounds 
have antiviral activity against several types of viruses, 
including RSV, HBV, and HIV [56]. These 
nanoparticles can also be used in air filters [55] and 
clothing fabrics [57]. 
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8. Nano-based vaccines 
Many efforts are currently underway to develop 
the COVID-19 vaccine, including clinical trials. 
Nanotechnology approaches can help develop nano-
based vaccines. The apparent similarity of SARS-CoV-
2 with other viruses (mainly SARS-CoV-2 and MERS-
CoV) and the therapeutic progress and challenges of 
SARS-CoV-2 infection with other infectious diseases 
as well as oncological research are not significantly 
different [58], and it can help a lot in making a 
successful COVID-19 vaccine [59]. 
Vaccine production has significant similarities in 
the fight against SARS, MERS coronaviruses [16]. On 
the other hand, Conventional vaccines have problems 
such as the risk of reversal of viral virulence (live 
attenuated virus vaccines), weak immune response 
(inactivated viruses), and limited immunogenicity 
(subunit vaccines) [15]. 
Another advantage of vaccine nanocarriers is their 
size. Many biological systems, such as viruses, 
including the SARS-CoV-2 virus and some proteins, 
are nano-scale [16]. In this way, nanoparticles can be 
loaded with a wide range of antigenic components 
which is very important in the production of vaccines 
[60]. Nanoparticles can also target both humoral 
immune systems and cell-mediated immunity [61]. 
Modulation of antigen-presenting cells (APCs) using 
nanoparticles is of particular importance in vaccine 
fabrication [62]. Organic nanoparticles such as 
liposomes, lipid-based NPs, and polymeric NPs are 
significant in vaccine formulations [24]. Also, 
biopolymer-based NPs, like protein-based NPs, have 
low toxicity and biodegradability [63]. AuNPs, as 
another nanosystem for vaccine production, have 
been studied on more than 45 pathogens in various 
sizes, shapes, and functions [64]. 
 
9. Conclusion 
The outbreak of the COVID-19 virus over the past 
year has led to the infection of a large population of the 
world and high mortality. As a result, rapid progress in 
discovering ways to diagnose, treat, and control the 
disease is a necessity. Early and rapid diagnosis of the 
disease, rapid and effective treatment measures, the 
use of appropriate and safe equipment are the most 
important strategies to control the disease. Currently, 
the diagnosing method of this disease is time-
consuming and it is not applicable in public 
populations and far from urban health centers. On the 
other hand, many therapeutic approaches to this 
disease are based on symptomatic treatment and are 
performed using antiviral drugs previously used in 
other viral diseases. These drugs prevent the virus 
from being absorbed into the tissue and block the 
activity of proteases in infected cells. However, this 
strategy only reduces the number of viruses and the 
symptoms. According to reports, the most important 
barrier to the use of these drugs is their delivery to 
target cells and tissues in the respiratory tract, which 
reduces their effectiveness. 
Use methods based on nanotechnology is one of 
the best ways to overcome these barriers. Due to the 
aerodynamic size of the nanoparticles, they can be 
effective in predicting the treatment process. Also, the 
lack of an approved vaccine with high efficacy and low 
side effects is another problem and obstacle in 
controlling the disease. The unpredictable and 
unknown nature of the disease and the similarity of the 
specific properties of COVID-19 and the 
physicochemical properties of nanosystems have led 
to the discussion of solutions based on new 
technologies. 
This study attempts to review possible strategies 
for the prevention, diagnosis, and treatment of 
COVID-19 by focusing on current experiences and 
knowledge about nanotechnology and its successful 
measures in curing other viral diseases. The use of 
proprietary antiviral drugs, animal models, in vitro 
and in vivo studies to help screen for antiviral drugs, 
prevent disease transmission, and produce vaccines 
with minimal side effects and high efficacy as soon as 
possible will determine the prospects of disease 
control. In summary, nanotechnology is a powerful 
multidisciplinary tool that has a variety of approaches 
and strategies to improve the development of 
coronavirus control and treatment. 
 
Author Contributions 
EM, MH, MG conceptualized and designed the 
study. EM, MH, MK, KD data collection. EM, MH, HS, 
MK, KD, MG drafted the manuscript, and revised the 
final version of manuscript.  
 
Conflict of Interests 
The authors declare that they have no conflicts of 
interest. 
 
Ethical declarations  








1. Rehman SU, Shafique L, Ihsan A, Liu Q. Evolutionary Trajectory 
for the Emergence of Novel Coronavirus SARS-CoV-2. Pathogens. 
2020; 9(3):240. 
2. Ruiz-Hitzky E, Darder M, Wicklein B, Ruiz-Garcia C, Martín-
Sampedro R, Del Real G, et al. Nanotechnology Responses to 
COVID-19. Adv Healthc Mater. 2020; 9(19):e2000979. 
3. Ou X, Liu Y, Lei X, Li P, Mi D, Ren L, et al. Characterization of 
spike glycoprotein of SARS-CoV-2 on virus entry and its immune 
cross-reactivity with SARS-CoV. Nat Commun. 2020; 11(1):1620. 
4. Zumla A, Chan JF, Azhar EI, Hui DS, Yuen KY. Coronaviruses - 
drug discovery and therapeutic options. Nat Rev Drug Discov. 
2016; 15(5):327-47. 
5. Khan M, Adil SF, Alkhathlan HZ, Tahir MN, Saif S, Khan M, et 
al. COVID-19: A Global Challenge with Old History, Epidemiology 
and Progress So Far. Molecules. 2020; 26(1):39. 
6. Forster P, Forster L, Renfrew C, Forster M. Phylogenetic 
network analysis of SARS-CoV-2 genomes. Proc Natl Acad Sci 
USA. 2020; 117(17):9241-3. 
7. Guan WJ, Ni ZY, Hu Y, Liang WH, Ou CQ, He JX, et al. Clinical 
Characteristics of Coronavirus Disease 2019 in China. N Engl J 
Med. 2020; 382(18):1708-20. 
8. Tang Z, Zhang X, Shu Y, Guo M, Zhang H, Tao W. Insights from 
nanotechnology in COVID-19 treatment. Nano Today. 2021; 
36:101019. 
9. Walls AC, Park YJ, Tortorici MA, Wall A, McGuire AT, Veesler 
D. Structure, Function, and Antigenicity of the SARS-CoV-2 Spike 
Glycoprotein. Cell. 2020; 181(2):281-92.e6. 
10. Tian X, Li C, Huang A, Xia S, Lu S, Shi Z, et al. Potent binding 
of 2019 novel coronavirus spike protein by a SARS coronavirus-
specific human monoclonal antibody. Emerg Microbes Infect. 
2020; 9(1):382-5. 
11. Mizumoto K, Kagaya K, Zarebski A, Chowell G. Estimating the 
asymptomatic proportion of coronavirus disease 2019 (COVID-19) 
cases on board the Diamond Princess cruise ship, Yokohama, 
Japan, 2020. Euro Surveill. 2020; 25(10):2000180. 
12. Grein J, Ohmagari N, Shin D, Diaz G, Asperges E, Castagna A, 
et al. Compassionate Use of Remdesivir for Patients with Severe 
Covid-19. N Engl J Med. 2020; 382(24):2327-36. 
13. Bhavana V, Thakor P, Singh SB, Mehra NK. COVID-19: 
Pathophysiology, treatment options, nanotechnology approaches, 
and research agenda to combating the SARS-CoV2 pandemic. Life 
Sci. 2020; 261:118336. 
14. UK researchers launch trial of blood plasma therapy for Covid-
19. UK researchers launch trial of blood plasma therapy for Covid-
19 2020 [updated May 4th, 2020]. Available at: 
https://www.clinicaltrialsarena.com/news/uk-blood-plasma-
covid-19-trial/. 
15. Jindal S, Gopinath P. Nanotechnology based approaches for 
combatting COVID-19 viral infection. Nano Express. 2020 1(2). 
16. Chauhan G, Madou MJ, Kalra S, Chopra V, Ghosh D, Martinez-
Chapa SO. Nanotechnology for COVID-19: Therapeutics and 
Vaccine Research. ACS Nano. 2020; 14(7):7760-82. 
17. Luo F, Long C, Wu Z, Xiong H, Chen M, Zhang X, et al. 
Functional silica nanospheres for sensitive detection of H9N2 
avian influenza virus based on immunomagnetic separation. Sens 
Actuators B Chem. 2020; 310:127831. 
18. Singh R, Hong S, Jang J. Label-free detection of influenza 
viruses using a reduced graphene oxide-based electrochemical 
immunosensor integrated with a microfluidic platform. Sci Rep. 
2017; 7:42771. 
19. Lara HH, Ayala-Nuñez NV, Ixtepan-Turrent L, Rodriguez-
Padilla C. Mode of antiviral action of silver nanoparticles against 
HIV-1. J Nanobiotechnology. 2010; 8:1. 
20. Yang X, Li C, Huang C. Curcumin modified silver nanoparticles 
for highly efficient inhibition of respiratory syncytial virus 
infection. Nanoscale. 2016; 8(5):3040-8. 
21. Mhlwatika Z, Aderibigbe B. Application of dendrimers for the 
treatment of infectious diseases. Molecules. 2018; 23(9):2205. 
22. Pollock S, Nichita N, Böhmer A, Radulescu C, Dwek R, 
Zitzmann N. Polyunsaturated liposomes are antiviral against 
hepatitis B and C viruses and HIV by decreasing cholesterol levels 
in infected cells. Proc Natl Acad Sci U S A. 2010; 107(40):17176-81. 
23. Wang N, Wei C, Zhang Z, Liu T, Wang T. Aluminum 
Nanoparticles Acting as a Pulmonary Vaccine Adjuvant-Delivery 
System (VADS) Able to Safely Elicit Robust Systemic and Mucosal 
Immunity. J Inorg Organomet Polym Mater. 2020; 30:4203-17. 
24. Cardoso VMdO, Moreira BJ, Comparetti EJ, Sampaio I, 
Ferreira LMB, Lins PMP, et al. Is Nanotechnology Helping in the 
Fight Against COVID-19? Frontiers in Nanotechnology. 2020; 
2(4):588915. 
25. Weiss C, Carriere M, Fusco L, Capua I, Regla-Nava JA, Pasquali 
M, et al. Toward Nanotechnology-Enabled Approaches against the 
COVID-19 Pandemic. ACS Nano. 2020; 14(6):6383-406. 
26. Nurul Najian AB, Engku Nur Syafirah EA, Ismail N, Mohamed 
M, Yean CY. Development of multiplex loop mediated isothermal 
amplification (m-LAMP) label-based gold nanoparticles lateral 
flow dipstick biosensor for detection of pathogenic Leptospira. 
Anal Chim Acta. 2016; 903:142-8. 
27. Mozhgani SH, Kermani HA, Norouzi M, Arabi M, Soltani S. 
Nanotechnology based strategies for HIV-1 and HTLV-1 
retroviruses gene detection. Heliyon. 2020; 6(5):e04048. 
28. Kim H, Park M, Hwang J, Kim JH, Chung DR, Lee KS, et al. 
Development of Label-Free Colorimetric Assay for MERS-CoV 
Using Gold Nanoparticles. ACS Sens. 2019; 4(5):1306-12. 
29. Zhu X, Wang X, Han L, Chen T, Wang L, Li H, et al. Multiplex 
reverse transcription loop-mediated isothermal amplification 
combined with nanoparticle-based lateral flow biosensor for the 
diagnosis of COVID-19. Biosens Bioelectron. 2020; 166:112437. 
30. Huang Y, Xu T, Wang W, Wen Y, Li K, Qian L, et al. Lateral flow 
biosensors based on the use of micro- and nanomaterials: a review 
on recent developments. Mikrochim Acta. 2019; 187(1):70. 
31. Layqah LA, Eissa S. An electrochemical immunosensor for the 
corona virus associated with the Middle East respiratory syndrome 
using an array of gold nanoparticle-modified carbon electrodes. 
Mikrochim Acta. 2019; 186(4):224. 
32. Amanat F, Krammer F. SARS-CoV-2 Vaccines: Status Report. 
Immunity. 2020; 52(4):583-9. 
33. Chen WH, Strych U, Hotez PJ, Bottazzi ME. The SARS-CoV-2 
Vaccine Pipeline: an Overview. Curr Trop Med Rep. 2020:1-4. 
Maghareh Abed et al. 
7 
34. Kerry RG, Malik S, Redda YT, Sahoo S, Patra JK, Majhi S. 
Nano-based approach to combat emerging viral (NIPAH virus) 
infection. Nanomedicine. 2019; 18:196-220. 
35. Khanal M, Vausselin T, Barras A, Bande O, Turcheniuk K, 
Benazza M, et al. Phenylboronic-acid-modified nanoparticles: 
potential antiviral therapeutics. ACS Appl Mater Interfaces. 2013; 
5(23):12488-98. 
36. Łoczechin A, Séron K, Barras A, Giovanelli E, Belouzard S, 
Chen YT, et al. Functional Carbon Quantum Dots as Medical 
Countermeasures to Human Coronavirus. ACS Appl Mater 
Interfaces. 2019; 11(46):42964-74. 
37. Huang X, Li M, Xu Y, Zhang J, Meng X, An X, et al. Novel Gold 
Nanorod-Based HR1 Peptide Inhibitor for Middle East 
Respiratory Syndrome Coronavirus. ACS Appl Mater Interfaces. 
2019; 11(22):19799-807. 
38. Du T, Liang J, Dong N, Lu J, Fu Y, Fang L, et al. Glutathione-
Capped Ag(2)S Nanoclusters Inhibit Coronavirus Proliferation 
through Blockage of Viral RNA Synthesis and Budding. ACS Appl 
Mater Interfaces. 2018; 10(5):4369-78. 
39. Ghaffari H, Tavakoli A, Moradi A, Tabarraei A, Bokharaei-
Salim F, Zahmatkeshan M, et al. Inhibition of H1N1 influenza virus 
infection by zinc oxide nanoparticles: another emerging 
application of nanomedicine. J Biomed Sci. 2019; 26(1):70. 
40. Razzaque MS. COVID-19 Pandemic: Can Maintaining Optimal 
Zinc Balance Enhance Host Resistance? Tohoku J Exp Med. 2020; 
251(3):175-81. 
41. Kobayashi K, Wei J, Iida R, Ijiro K, Niikura K. Surface 
engineering of nanoparticles for therapeutic applications. Polymer 
J. 2014; 46(8):460-8. 
42. Milovanovic M, Arsenijevic A, Milovanovic J, Kanjevac T, 
Arsenijevic N. Chapter 14 - Nanoparticles in Antiviral Therapy. In: 
Grumezescu AM, editor. Antimicrobial Nanoarchitectonics: 
Elsevier; 2017. p. 383-410. 
43. Chang D, Xu H, Rebaza A, Sharma L, Dela Cruz CS. Protecting 
health-care workers from subclinical coronavirus infection. Lancet 
Respir Med. 2020; 8(3):e13. 
44. Warnes SL, Little ZR, Keevil CW. Human Coronavirus 229E 
Remains Infectious on Common Touch Surface Materials. mBio. 
2015; 6(6):e01697-15. 
45. Kampf G, Todt D, Pfaender S, Steinmann E. Persistence of 
coronaviruses on inanimate surfaces and their inactivation with 
biocidal agents. J Hosp Infect. 2020; 104(3):246-51. 
46. Ong S, Tan Y, Chia P, Lee T, Ng O, Wong M, et al. Air, surface 
environmental, and personal protective equipment contamination 
by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-
2) from a symptomatic patient. JAMA. 2020; 323(16):1610-2. 
47. Murphy F, Tchetchik A, Furxhi I. Reduction of Health Care-
Associated Infections (HAIs) with Antimicrobial Inorganic 
Nanoparticles Incorporated in Medical Textiles: An Economic 
Assessment. Nanomaterials (Basel). 2020; 10(5):999. 
48. Palza H, Nuñez M, Bastías R, Delgado K. In situ antimicrobial 
behavior of materials with copper-based additives in a hospital 
environment. Int J Antimicrob Agents. 2018; 51(6):912-7. 
49. Iyigundogdu ZU, Demir O, Asutay AB, Sahin F. Developing 
Novel Antimicrobial and Antiviral Textile Products. Appl Biochem 
Biotechnol. 2017; 181(3):1155-66. 
50. Akhavan O, Choobtashani M, Ghaderi E. Protein degradation 
and RNA efflux of viruses photocatalyzed by graphene–tungsten 
oxide composite under visible light irradiation. J Phys Chem C. 
2012; 116(17):9653-9. 
51. Balagna C, Perero S, Percivalle E, Nepita EV, Ferraris M. 
Virucidal effect against coronavirus SARS-CoV-2 of a silver 
nanocluster/silica composite sputtered coating. Open Ceram. 
2020; 1:100006.  
52. Nakashima R, Kawamoto M, Miyazaki S, Onishi R, Furusaki K, 
Osaki M, et al. Evaluation of calcium hydrogen carbonate 
mesoscopic crystals as a disinfectant for influenza A viruses. J Vet 
Med Sci. 2017; 79(5):939-42. 
53. Sakudo A, Yamashiro R, Haritani M, Furusaki K, Onishi R, 
Onodera T. Inactivation of Non-Enveloped Viruses and Bacteria by 
an Electrically Charged Disinfectant Containing Meso-Structure 
Nanoparticles via Modification of the Genome. Int J 
Nanomedicine. 2020; 15:1387-95. 
54. Pfaff F, Glück B, Hoyer T, Rohländer D, Sauerbrei A, Zell R. 
Tungsten carbide nanoparticles show a broad spectrum virucidal 
activity against enveloped and nonenveloped model viruses using 
a guideline‐standardized in vitro test. Lett Appl Microbiol. 2019; 
69:302-9. 
55. Deshmukh SP, Patil SM, Mullani SB, Delekar SD. Silver 
nanoparticles as an effective disinfectant: A review. Mater Sci Eng 
C Mater Biol Appl. 2019; 97:954-65. 
56. Galdiero S, Falanga A, Vitiello M, Cantisani M, Marra V, 
Galdiero M. Silver nanoparticles as potential antiviral agents. 
Molecules. 2011; 16(10):8894-918. 
57. Noor N, Mutalik S, Younas MW, Chan CY, Thakur S, Wang F, 
et al. Durable Antimicrobial Behaviour from Silver-Graphene 
Coated Medical Textile Composites. Polymers (Basel). 2019; 
11(12):2000. 
58. Kostarelos K. Nanoscale nights of COVID-19. Nat 
Nanotechnol. 2020; 15(5):343-4. 
59. Lurie N, Saville M, Hatchett R, Halton J. Developing Covid-19 
Vaccines at Pandemic Speed. N Engl J Med. 2020; 382(21):1969-
73. 
60. Park YM, Lee SJ, Kim YS, Lee MH, Cha GS, Jung ID, et al. 
Nanoparticle-based vaccine delivery for cancer immunotherapy. 
Immune Netw. 2013; 13(5):177-83. 
61. Graham RL, Becker MM, Eckerle LD, Bolles M, Denison MR, 
Baric RS. A live, impaired-fidelity coronavirus vaccine protects in 
an aged, immunocompromised mouse model of lethal disease. Nat 
Med. 2012; 18(12):1820-6. 
62. Steinman RM, Banchereau J. Taking dendritic cells into 
medicine. Nature. 2007; 449(7161):419-26. 
63. Lohcharoenkal W, Wang L, Chen YC, Rojanasakul Y. Protein 
nanoparticles as drug delivery carriers for cancer therapy. Biomed 
Res Int. 2014; 2014:180549. 
64. Dykman LA. Gold nanoparticles for preparation of antibodies 
and vaccines against infectious diseases. Expert Rev Vaccines. 
2020; 19(5):465-77. 
 
